Literature DB >> 3084340

Mucus degradation by pepsin: comparison of mucolytic activity of human pepsin 1 and pepsin 3: implications in peptic ulceration.

J P Pearson, R Ward, A Allen, N B Roberts, W H Taylor.   

Abstract

The ability to digest mucus, mucolytic activity of isolated pepsins and samples of human gastric juice has been assayed by measuring the fall in viscosity when incubated with purified pig gastric mucus glycoprotein. Pure human pepsin 1, the peptic ulcer associated pepsin, digested gastric mucus glycoprotein at a faster rate than did pure human pepsin 3 (the principal human pepsin), or the equivalent pig pepsin (pepsin A). At pH 2.0 pepsin 1 had twice the mucolytic activity of pepsin 3. Above pH 3.8 this difference became more marked and whereas pepsin 1 caused substantial mucolysis up to and including pH 5.1, pepsin 3 had minimal activity. At pH 4.0 pepsin 1 had six times the mucolytic activity of pepsin 3. Gastric juices from patients with duodenal ulcer each exhibited substantial mucolytic activity between pH 2 to 5, similar to that of pepsin 1. In contrast, gastric juice from non-symptomatic volunteers exhibited little mucolytic activity above pH 4. Analysis of the mucus glycoprotein by gel filtration showed that an increase in lower molecular weight, pepsin degraded, glycoprotein was associated with the fall in mucus viscosity for all enzyme preparations. These results showed that pepsin 1 can digest the mucus more effectively than pepsin 3 and at higher pH values. The raised concentrations of pepsin 1 in the juice of peptic ulcer patients may thus promote the ulcerative process by increased erosion of the mucus barrier under conditions likely to pertain in the duodenal bulb as well as the stomach.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3084340      PMCID: PMC1433406          DOI: 10.1136/gut.27.3.243

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  Variation in the proportions of individual pepsins secreted by the cat in response to vagal stimulation and hypoglycaemia.

Authors:  C L Wright; B Shaw; D J Sanders; J D Reed
Journal:  Clin Sci Mol Med       Date:  1975-04

2.  Gastric proteolysis in disease. 2. The proteolytic activity of gastric juice and gastric mucosal extracts from patients with chronic gastric and duodenal ulcer.

Authors:  W H TAYLOR
Journal:  J Clin Pathol       Date:  1959-07       Impact factor: 3.411

3.  The action of proteolytic enzymes on the glycoprotein from pig gastric mucus.

Authors:  M Scawen; A Allen
Journal:  Biochem J       Date:  1977-05-01       Impact factor: 3.857

Review 4.  Structure of gastrointestinal mucus glycoproteins and the viscous and gel-forming properties of mucus.

Authors:  A Allen
Journal:  Br Med Bull       Date:  1978-01       Impact factor: 4.291

5.  The preparation and purification of individual human pepsins by using diethylaminoethyl-cellulose.

Authors:  N B Roberts; W H Taylor
Journal:  Biochem J       Date:  1978-03-01       Impact factor: 3.857

6.  An assessment of the value of measuring uncollected gastric secretion during routine secretion studies in man.

Authors:  C W Venables
Journal:  Br J Surg       Date:  1972-06       Impact factor: 6.939

7.  Electrophoretic heterogeneity and relationships of pepsinogens in human urine, serum, and gastric mucosa.

Authors:  I M Samloff; P L Townes
Journal:  Gastroenterology       Date:  1970-04       Impact factor: 22.682

8.  Pepsins of patients with peptic ulcer.

Authors:  W H Taylor
Journal:  Nature       Date:  1970-07-04       Impact factor: 49.962

9.  Acidity at different sites in the proximal duodenum of normal subjects and patients with duodenal ulcer.

Authors:  J Rhodes; C J Prestwich
Journal:  Gut       Date:  1966-10       Impact factor: 23.059

10.  The pepsins from human gastric mucosal extracts.

Authors:  D J Etherington; W H Taylor
Journal:  Biochem J       Date:  1970-07       Impact factor: 3.857

View more
  22 in total

1.  Somatostatin adjunctive therapy for non-variceal upper gastrointestinal rebleeding after endoscopic therapy.

Authors:  Cheol Woong Choi; Dae Hwan Kang; Hyung Wook Kim; Su Bum Park; Kee Tae Park; Gwang Ha Kim; Geun Am Song; Mong Cho
Journal:  World J Gastroenterol       Date:  2011-08-07       Impact factor: 5.742

2.  Meaning of measurement of bound sialic acid output in human gastric juice.

Authors:  J Vatier; C Poitevin; M Mignon
Journal:  Dig Dis Sci       Date:  1989-06       Impact factor: 3.199

3.  Substrate and inhibitor studies with human gastric aspartic proteinases.

Authors:  A Baxter; C J Campbell; C J Grinham; R M Keane; B C Lawton; J E Pendlebury
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

4.  Structural and compositional differences between intracellular and secreted mucin of rat small intestine.

Authors:  R E Fahim; G G Forstner; J F Forstner
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

5.  Effect of repeated boluses of intravenous omeprazole and primed infusions of ranitidine on 24-hour intragastric pH in healthy human subjects.

Authors:  S Teyssen; S T Chari; J Scheid; M V Singer
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

6.  The diurnal profile of gastric pepsin activity is reduced with Helicobacter pylori infection.

Authors:  J L Newton; O F W James; G V Williams; A Allen
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

7.  Ulcerogenic and intestinal motility/transit stimulating actions of nevirapine in albino Wistar rats.

Authors:  Elizabeth Bassey Umoren; Agona Odeh Obembe; Eme Effiom Osim
Journal:  J Physiol Biochem       Date:  2013-03-28       Impact factor: 4.158

8.  Large single daily dose of histamine H2 receptor antagonist for duodenal ulcer. How much and when? A clinical pharmacological study.

Authors:  M Deakin; H P Glenny; J K Ramage; J G Mills; W L Burland; J G Williams
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

9.  Assay of gastricsin and individual pepsins in human gastric juice.

Authors:  A T Jones; K K Balan; S A Jenkins; R Sutton; M Critchley; N B Roberts
Journal:  J Clin Pathol       Date:  1993-03       Impact factor: 3.411

10.  Prostaglandin E2 in gastric mucosa of children with Helicobacter pylori gastritis: relation to thickness of mucus gel layer.

Authors:  G Oderda; M D'Alessandro; P Mariani; P Lionetti; M Bonamico; D Dell'Olio; N Ansaldi
Journal:  J Clin Pathol       Date:  1993-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.